Allard, Hébert, Rioux, Asselin, and Voyer (2001). “Efficacy of a Clinical Medication Review on the Number of Potentially Inappropriate Prescriptions Prescribed for Community-Dwelling Elderly People.” Canadian Medical Association Journal, 164(9), 1291-1296.
Álvarez, F. J., and del Río, C. (2002). “Medicinal Drugs and Driving: from Research to Clinical Practice.” Trends in Pharmacological Sciences, 23(9), 441-443.
American Pharmacists Association/APhA. (2003). Medication Compliance-Adherence-Persistence (CAP) Digest. American Pharmacists Association and Pfizer Pharmaceuticals. Washington, D.C.
Aparasu, R.R. and Mort, J.R. (2004). “Prevalence, Correlates, and Associated Outcomes of Potentially Inappropriate Psychotropic Use in the Community-Dwelling Elderly.” The American Journal of Geriatric Pharmacotherapy, 2(2), 102-111.
Becker, M.H., Maiman, L.A. (1975). “Sociobehavioral Determinants of Compliance with Health and Medical Care Recommendations.” Med Care, 13(1):10-24.
Bikowski, R.M., Ripsin, C.M., and Lorraine, V.L. (2001). “Physician-Patient Congruence Regarding Medication Regimes.” Journal of the American Geriatrics Society, 49, 1353-1357.
Caskie, G. and Willis, S. (2004). “Congruence of Self-Reported Medications with Pharmacy Prescription Records in Low-Income Older Adults.” The Gerontologist, 44, 176-185.
Coons, S.J. (2001). “Medication Compliance: the Search for Answers Continues.” Clin Ther, 23, 1294-1295.
Farris, K.B., Ganther-Urmie, J.M., Fang, G., Doucette, W.R., Brooks, J.M., Klepser, D.K., Fries, D.J., and Kuhle, C.L. (2004). “Population-Based Medication Reviews: A Descriptive Analysis of the Medication Issues Identified in a Medicare Not-for-Profit Prescription Discount Program.” The Annals of Pharmacotherapy, 38, 1823-1829.
Fick, D.M., Cooper, J.W., Wade, W.E., Waller, J.L., Maclean, J.R. and Beers, M.H. (2003). “Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults: Results of a US Consensus Panel of Experts.” Arch. Intern. Med. 163:2716-2724.
Fishbain, D.A., Cutler, R.B., Rosomoff, H.L., and Rosomoff, R.S. (2003). “Are Opioid-Dependent/Tolerant Patients Impaired in Driving-Related Skills: A Structured Review. Journal of Pain and System Management, 25(6), 559-577.
Gurwitz, J.H., Field, T.S., Harrold, L.R., Rothschild, J., Debellis, K., Seger, A.C., Cadoret, C., Fish, L.S., Garber, L., Kelleher, M., and Bates, D.W. (2003). “Incidence and preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting.” Journal of the American Medical Association, 289(9), 1107-1116.
Herrlinger, C. and Klotz, U. (2001). “Drug Metabolism and Drug Interactions in the Elderly.” Best Practice & Research Clinical Gastroenterology, 15:897-918.
Keller, M., Kesselring, J., and Hiltbrunner, B. (2003). “Fitness to Drive with Neurological Disabilities.” Neurorehabiltation and Neural Repair, 17(3), 168-174.
Kinirons, M.T. and O'Mahony, M.S. (2004). “Drug Metabolism and Ageing.” Br. J. Clin. Pharmacol. 57:540-544.
LeRoy, A. (2004). Draft Report: Exploratory Study of the Relationship Between Multiple Medicines and Vehicle Crashes—Analysis of Databases. Unpublished manuscript, IATROGEN, Herndon, VA.
Leveille, S.G., Buchner, D.M., Koepsell, T.D., McCloskey, L.W., Wolf, M.E., and Gagner, E.H. (1994). “Psychoactive Medications and Injurious Motor Vehicle Collisions Involving Older Drivers.” Epidemiology, 5, pp. 591-598.
Liu, H., Golin, C.E., Miller, L.G., Hats, R.D., Beck, C.K., Sanandaji, B.S., et al. (2001). “A Comparison Study of Multiple Measures of Adherence to HIV Protease Inhibitors.” Annals of Internal Medicine, 134, 968-977.
MacRae, F., Lowrie, R., MacLaren, A., Kinn, S., and Fish, A. (2003). “Patient Views of Pharmacist-Led Medication Review Clinics: A Preliminary Qualitative Study.” The International Journal of Pharmacy Practice. September, 11:R6.
Marinker, M., Blenkinsopp, A., Bond, C. et al. (1997). From Compliance to Concordance: Achieving Shared Goals in Medicine Taking. London, UK: Royal Pharmaceutical Society of Great Britain. http://www.medicines-partnership.org/about-us/history.
Nankoong, K., Farren, C.K., O’Connor, P.G., and O’Mally, S.S. (1999). “Measurement of Compliance with Naltexone in the Treatment of Alcohol Dependence: Research and Clinical Implications. Journal of Clinical Psychiatry, 60(7), 449-453.
Nathan, A., Goodyer, L., Lovejoy, A., and Rashid, A. (1999). “Brown Bag Medication Reviews as a Means of Optimizing Patients’ Use of Medication and of Identifying Potential Clinical Problems. Family Practice, 16, 278-282.
Ory, M.G., Lipman, P.D., Karlen, P.L., Gerety, M.B., Stevens, V.J., Singh, M.A., Buchner, D.M., Schectman, K.B., and FICSIT Group. (2002). “Recruitment of Older Participants in Frailty/Injury Prevention Studies.” Prevention Science, 3(1), 1-22.
Ramaekers, J. (2003). “Antidepressants and Driver Impairment: Empirical Evidence from a Standard On-the-Road Test.” Journal of Clinical Psychiatry, 64(1), 20-29.
Schmucker, D.L. (2001). “Liver Function and Phase I Drug Metabolism in the Elderly: A Paradox.” Drugs Aging 18:837-851.
Sundet, K., Goffeng, L., and Hofft, E. (1995). “To Drive or Not to Drive: Neuropsychological Assessment for Driver’s License Among Stroke Patients.” Scandinavian Journal of Psychology, 36(1), 47-58.
Szlyk, J.P., Mahler, C.L., Seiple, W., Vajaranant, T.S., Blair, N.P., and Shahidi, M. (2004). “Relationship of Retinal Structural and Clinical Vision Parameters to Driving Performance of Diabetic Retinopathy Patients.” Journal of Rehabilitation Research and Development, 41(3A), 347-358.
Vik, S.A., Maxwell, C.J., and Hogan, D.B. (2004). “Measurement, Correlates, and Health Outcomes of Medication Adherence Among Seniors.” The Annals of Pharmacotherapy, 38, 303-312.
Walsh, J. M., de Gier, J.J., Christopherson, A.S., and Verstraete, A.G. (2004). “Drugs and Driving.” Traffic Injury Prevention, 5, 241-253.
Wilkinson, C. and Moskowitz, H. (2001). Polypharmacy and Older Drivers: Literature Review. Unpublished Manuscript, Southern California Research Institute, Los Angeles, CA.